about
Transcriptome sequencing to detect gene fusions in cancerExpressed pseudogenes in the transcriptional landscape of human cancersA comparison of single molecule and amplification based sequencing of cancer transcriptomesIntegrative analysis of genomic aberrations associated with prostate cancer progression.Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanomaFunctionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancerCoordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory responseGenomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.Chimeric transcript discovery by paired-end transcriptome sequencingA fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease.Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early Stage Lung Cancers.KRAS Engages AGO2 to Enhance Cellular Transformation.Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer.Characterization of bone metastases from rapid autopsies of prostate cancer patientsN-terminal PDZ-like domain of chromatin organizer SATB1 contributes towards its function as transcription regulator.Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.Human papillomavirus genotyping by multiplex pyrosequencing in cervical cancer patients from India.
P50
Q24653386-12C94E90-1226-4FD3-9388-962FA6C5EB11Q28703606-9FA5105A-F057-4317-B5ED-9067ED4562D4Q28742310-2B86E566-C1D4-4297-BD71-5A77923CB285Q33297464-7FAB3A1F-5581-4251-80AC-2B417404E63AQ33579776-522582D0-32C6-4CDE-9A65-57F803928ABEQ33992803-5D680B9F-BD65-4DCD-BD44-99259F3BE6ACQ35600870-3B57BDA7-14B6-42B2-896F-92688F598AD8Q36200413-7D0B0AE8-17CD-43D1-BE4C-481CAC326510Q36598417-4BD91B93-C078-4C59-81D9-BA0AF3922010Q37198891-3A6BF3A7-AAAB-4446-9137-833EA96B814FQ37257656-916D33BC-4AA0-4CBE-99FA-072816B236F7Q37383453-F58C186F-DEE0-4842-A788-C4A19D65CB0EQ37481159-EFE1A6FB-E8DB-4421-A970-F5108CBC3258Q38431117-689620BD-70F0-4BB3-8AA6-E4572633B417Q38548325-428D888E-2D96-4FA5-8558-11AA94665F98Q39243402-FBECC26E-B672-4A36-9BE7-CD6BD497DBECQ41855105-3A6B8124-A688-49F9-B3E6-21536155BCA5Q46283330-CC5ACFD8-6D35-41DF-B31E-126B1A086C26Q47282920-AB8C4F36-61D3-4614-B42A-439407CC8385Q54539774-7E512308-6BD0-4E83-B163-0260B37D1C07
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chandan Kumar-Sinha
@ast
Chandan Kumar-Sinha
@en
Chandan Kumar-Sinha
@es
Chandan Kumar-Sinha
@nl
Chandan Kumar-Sinha
@sl
type
label
Chandan Kumar-Sinha
@ast
Chandan Kumar-Sinha
@en
Chandan Kumar-Sinha
@es
Chandan Kumar-Sinha
@nl
Chandan Kumar-Sinha
@sl
prefLabel
Chandan Kumar-Sinha
@ast
Chandan Kumar-Sinha
@en
Chandan Kumar-Sinha
@es
Chandan Kumar-Sinha
@nl
Chandan Kumar-Sinha
@sl
P106
P1153
6507499436
P31
P496
0000-0002-8696-3400